基于造血干细胞治疗免疫系统的先天性错误的领域的进展
Danielle E Arnold1, Sung-Yun Pai
1Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Current opinion in pediatrics
|September 21, 2023
概括
造血干细胞疗法为免疫系统的先天性错误 (IEI) 提供治疗方法. 最近在全基造血细胞移植 (HCT) 和基因疗法 (GT) 的进展改善了SCID,WAS和CGD等疾病的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- 基于造血干细胞的疗法,包括全基造血干细胞移植 (HCT) 和自身基因疗法 (GT),已被确立为许多先天免疫错误 (IEI) 的治愈疗法.
- 越来越多的基因定义IEI和HCT和GT的扩大应用已经产生了有价值的结果数据和针对特定疾病的精细治疗方法.
研究的目的:
- 审查HCT和GT治疗IEI的最新进展.
- 突出管理并发症和扩大青少年和年轻成年人中HCT使用的进展.
- 分析SCID,WAS和CGD等特定IEI的结果,确定影响生存和治疗疗效的关键因素.
主要方法:
- 对IEI的HCT和GT近期进展的审查.
- 对SCID,威斯科特-阿尔德里奇综合征 (WAS) 和慢性颗粒性疾病 (CGD) 的HCT和GT结局结果的分析.
- 检查新的方法来预防异构并发症和青少年和年轻成年人的经验.
主要成果:
- 针对严重综合免疫缺陷 (SCID) 的全民新生儿查改善了HCT结果.
- 对SCID,WAS和CGD的HCT和GT分析确定了生存的风险因素和调节方案的影响.
- 基因疗法和基因编辑的临床前研究表明临床翻译具有前途.
结论:
- 新出现的数据支持对特定IEI的早期评估和治疗,以在并发症出现之前改善结果.
- 大规模的合作回顾数据库为临床医生关于患者选择和治疗选择的决策提供了宝贵的见解.
- 对HCT和GT的持续研究,包括基因编辑,对推进IEI治疗具有重大潜力.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Bone Marrow Sampling and Transplants
352
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
352
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K


